Diabetic Cardiomyopathy The Silent Heart Complication of Long-Standing Diabetes

On World Diabetes Day 2026, Dr Asadullah Soomro highlights how diabetes can damage the heart, why early detection matters and how preventive care can reduce cardiovascular risks.

Diabetic Cardiomyopathy and heart health awareness for World Diabetes Day 2026.

Diabetic Cardiomyopathy: World Diabetes Day highlights the importance of protecting heart health.

Diabetes can affect far more than blood sugar levels. Over time, it can damage the heart muscle, impair its ability to relax and pump blood, and increase the risk of heart failure. One important but frequently under-recognised complication is diabetic cardiomyopathy.

World Diabetes Day, observed every year on November 14, provides an opportunity to raise awareness about diabetes and its complications. This year, the focus is on a serious cardiac condition that may develop silently, even before noticeable symptoms appear.

Diabetes: A Growing Global and National Challenge

The International Diabetes Federation’s 2021 Diabetes Atlas estimated that 537 million adults worldwide were living with diabetes. Pakistan had approximately 32.9 million affected adults, representing an estimated prevalence of 26.7% among adults.

These figures placed Pakistan among the countries with the largest diabetes populations. The 2021 estimates also ranked Pakistan first globally for age-adjusted comparative diabetes prevalence. These are historical estimates, not updated 2026 figures.

Diabetes is associated with several cardiovascular complications. These include coronary artery disease, ischaemic stroke, peripheral arterial disease, heart failure and cardiovascular autonomic neuropathy. It can also contribute to other circulatory complications.

Diabetic cardiomyopathy deserves particular attention because it involves structural and functional damage to the heart muscle itself.

World Diabetes Day and the Discovery of Insulin

November 14 also marks the birthday of Sir Frederick Grant Banting, who was born in Ontario, Canada, on November 14, 1891. He died in February 1941.

Banting, Charles Best, John Macleod and James Collip played key roles in developing insulin as a treatment for diabetes. Their work became one of the most important medical breakthroughs of the twentieth century.

Rural LADIESFUND Investments Expands Women’s Financial Education to Fourth Sindh District

On January 11, 1922, 14-year-old Leonard Thompson became the first person to receive an insulin injection. However, the initial preparation produced limited results. A more purified preparation, administered on January 23, produced a successful response.

Eli Lilly later became the first manufacturer to mass-produce insulin. The company began shipping its first commercial supplies in October 1923.

Insulin remains essential for people with type 1 diabetes and plays an important role in treating many people with type 2 diabetes. Its use depends on individual clinical needs.

What Is Diabetic Cardiomyopathy?

Diabetic cardiomyopathy refers to structural or functional abnormalities of the heart muscle associated with diabetes. The condition is traditionally defined in the absence of other major explanations, particularly significant coronary artery disease, hypertension and valvular heart disease.

However, these conditions frequently coexist in people with diabetes. Therefore, doctors must carefully assess other possible causes before making a diagnosis.

The term was introduced in 1972 by Rubler and colleagues. Their research described heart muscle abnormalities in people with diabetes without evidence of major coronary artery disease.

How Does Diabetes Damage the Heart?

Long-term diabetes can affect the heart through several interconnected processes:

  • Persistent high blood sugar: Chronic hyperglycaemia disrupts normal heart-cell function and energy production.
  • Insulin resistance: Changes in how the heart uses glucose and fatty acids can affect its energy balance.
  • Oxidative stress: Excessive oxidative activity can injure heart cells and their internal structures.
  • Inflammation: Long-standing metabolic disturbances can trigger inflammatory processes in the heart.
  • Mitochondrial injury: Damage to cellular energy-producing structures can reduce the heart muscle’s efficiency.
  • Advanced glycation end products: These compounds can contribute to tissue damage and increased stiffness.
  • Myocardial fibrosis: Excessive connective tissue can develop within the heart muscle, making it less flexible.

Together, these changes may interfere with the heart’s ability to relax and fill with blood. In some patients, they can also weaken its pumping function.

Clinical Signs: From Silent Changes to Heart Failure

Diabetic cardiomyopathy may develop gradually. Early changes can occur without obvious symptoms.

Early or subclinical stage

Some patients may have no noticeable symptoms. However, medical imaging may reveal impaired relaxation, changes in heart muscle structure, left ventricular thickening or abnormal myocardial strain.

When structural or functional heart abnormalities exist without clinical heart failure symptoms, doctors may classify the condition within the pre-heart-failure stage.

Later or symptomatic stage

As the condition progresses, patients may experience:

  • Shortness of breath, particularly during physical activity
  • Reduced exercise tolerance
  • Swelling in the legs or ankles
  • Persistent fatigue
  • Symptoms of heart failure

Depending on the patient’s heart function, the condition may present as heart failure with preserved, mildly reduced or reduced ejection fraction.

Some patients may eventually develop advanced heart failure requiring specialised treatment.

Diagnosis: Why Early Detection Matters

Diagnosing diabetic cardiomyopathy requires a detailed clinical assessment. Doctors consider the patient’s diabetes history, blood sugar control, blood pressure, kidney function, medication history and possible alternative causes of heart disease.

Investigations may include:

Electrocardiogram (ECG): Helps assess the heart’s electrical activity and identify possible abnormalities.

Echocardiography: Uses ultrasound to examine heart structure, chamber size, wall thickness, relaxation and pumping function. Global longitudinal strain may also help identify subtle changes in heart muscle performance.

HbA1c testing: Measures average blood glucose levels over approximately three months. It helps assess diabetes control but does not independently diagnose cardiomyopathy.

Blood biomarkers: BNP or NT-proBNP may help assess suspected heart failure. Troponin testing may identify heart muscle injury when clinically indicated. Neither test specifically confirms diabetic cardiomyopathy.

Cardiac MRI: Provides detailed information about heart structure, tissue characteristics and possible fibrosis. Doctors may use it when further investigation is necessary.

Coronary imaging, stress testing and other specialised investigations may help exclude alternative causes. Invasive procedures and heart muscle biopsy are reserved for selected cases.

There is currently no single test that independently confirms diabetic cardiomyopathy. Doctors must interpret clinical findings and investigations together.

Treatment: Protecting the Heart and Managing Diabetes

Treatment focuses on controlling diabetes, reducing cardiovascular risks and managing heart failure when present.

Important approaches include:

  • Blood sugar management: Maintain individualised glucose targets through appropriate medication, nutrition and regular medical follow-up.
  • SGLT2 inhibitors: These medicines can reduce heart failure risks and improve outcomes in eligible patients, depending on their clinical condition.
  • GLP-1 receptor agonists: These medicines can offer metabolic and cardiovascular benefits for selected people with type 2 diabetes.
  • Heart failure treatment: Patients with heart failure may require guideline-directed medicines based on their ejection fraction and overall condition.
  • Blood pressure and cholesterol control: Managing hypertension and abnormal cholesterol levels helps reduce cardiovascular risks.
  • Kidney and weight management: Addressing kidney disease, obesity and other associated conditions forms an important part of treatment.

Gene therapy and stem-cell approaches remain experimental for diabetic cardiomyopathy. They are not established routine treatments.

Treatment decisions must be individualised according to age, kidney function, other medical conditions and the patient’s overall health.

Prevention Is Powerful

Healthy daily habits can help reduce the risk of diabetes-related cardiovascular complications.

A heart-healthy diet should include more vegetables, fruits, legumes, whole grains and nuts. People should also limit excessive salt, refined sugar and highly processed foods.

Regular physical activity supports cardiovascular health and helps improve blood sugar control. Walking, where medically appropriate, can provide a practical way to remain active.

Avoiding tobacco, maintaining healthy sleep habits and attending regular medical check-ups are also important.

People living with diabetes should follow their prescribed treatment plans and discuss any new symptoms with their healthcare professionals.

A Message for Families and Communities

Financial and educational resources are not the only foundations of better health. Awareness, access to healthcare and informed decisions within families also matter.

Investing in girls’ education can strengthen health awareness across generations. Families that understand diabetes, its warning signs and its complications can seek medical attention earlier.

Walking to the mosque for Salah can also provide an opportunity for physical activity for people who are able. However, safe and inclusive exercise options should remain available to everyone.

Communities can help prevent complications by encouraging healthy eating, regular movement, diabetes screening and timely medical care.

World Diabetes Day 2026: Protect the Heart Before Symptoms Appear

The message for World Diabetes Day is clear:

“Time is Myocardium — and Myocardium is Life.”

The heart muscle deserves attention before symptoms develop. Early recognition, appropriate diabetes management and control of cardiovascular risk factors can help protect heart health.

Dr Asadullah Soomro is associated with Altamash General Hospital, Clifton, Karachi.

For questions or comments, contact:

Follow THE AZB

Leave a Reply

Your email address will not be published. Required fields are marked *

Social Media Auto Publish Powered By : XYZScripts.com